ABIONYX Pharma Reports Positive Results from Phase 2a Pilot …
TOULOUSE, France & LAKELAND, Mich.–(BUSINESS WIRE)–Regulatory News: ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today reported that the pilot Phase 2a clinical trial evaluating CER-001, the only natural recombinant apoA-I, as a treatment for septic patients at […] ABIONYX Pharma Reports Positive Results from Phase 2a Pilot …
News
0
0
TOULOUSE, France & LAKELAND, Mich.–(BUSINESS WIRE)–Regulatory News: ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today reported that the pilot Phase 2a clinical trial evaluating CER-001, the only natural recombinant apoA-I, as a treatment for septic patients at […]
ABIONYX Pharma Reports Positive Results from Phase 2a Pilot …
![Brighton vs Arsenal 2:4 [Full Time]](https://i0.wp.com/hgsmediaplus.com/wp-content/uploads/2022/12/Brighton-Vs-Arsenal.jpeg?fit=275%2C183&ssl=1){kind=small}
